Table 3.
Clinical features |
LncRNA CRNDE expression |
miR-181a-5p expression |
||||||
---|---|---|---|---|---|---|---|---|
High | Low | χ2 Value | P Value | High | Low | χ2 Value | P Value | |
Gender | ||||||||
Female | 35 | 31 | 31 | 35 | ||||
Male | 46 | 24 | 2.27 | 0.132 | 27 | 43 | 0.98 | 0.322 |
Age | ||||||||
≥ 56.04 | 39 | 32 | 35 | 36 | ||||
< 56.04 | 42 | 23 | 1.32 | 0.250 | 23 | 42 | 2.69 | 0.101 |
MAP score | ||||||||
≥ 0.34 | 62 | 30 | 31 | 61 | ||||
< 0.34 | 19 | 25 | 7.24 | 0.007 | 27 | 17 | 9.32 | 0.002 |
SOFA score | ||||||||
≥ 7.64 | 52 | 24 | 23 | 53 | ||||
< 7.64 | 29 | 31 | 5.62 | 0.018 | 35 | 25 | 10.80 | 0.001 |
APACHE II score | ||||||||
≥ 17.15 | 60 | 25 | 30 | 55 | ||||
< 17.15 | 21 | 30 | 11.45 | 0.001 | 28 | 23 | 5.01 | 0.025 |
WBC (×109/l) | ||||||||
≥ 14.37 | 52 | 27 | 28 | 51 | ||||
< 14.37 | 29 | 28 | 3.07 | 0.080 | 30 | 27 | 4.00 | 0.046 |
CRP (mg/l) | ||||||||
≥ 125 | 70 | 27 | 34 | 63 | ||||
< 125 | 11 | 28 | 22.32 | < 0.001 | 24 | 15 | 7.98 | 0.005 |
PCT (μg/l) | ||||||||
≥ 9.51 | 56 | 24 | 28 | 52 | ||||
< 9.51 | 25 | 31 | 8.79 | 0.003 | 30 | 26 | 4.65 | 0.031 |
MAP: mean arterial pressure; SOFA: sequential organ failure assessment; APACHE II: acute physiology and chronic health evaluation II; WBC: white blood cell count; CRP: C-reactive protein; PCT: procalcitonin.